Related Experiment Videos
Platelet glycoprotein IIb/IIIa antagonists in ischemic cerebrovascular disease
J R Leclerc1, M A Mascelli, H F Weisman
1Division of Cardiovascular Research, Lilly Research Laboratories, Indianapolis, Indiana 46285-2207, USA. Leclerc_Jacques_R@Lilly.com
Coronary Artery Disease
|December 22, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Cleaved secretory leucocyte protease inhibitor as a biomarker of chymase activity in allergic airway disease.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2009
Applicability and reproducibility of biomarkers for the evaluation of anti-inflammatory therapy in allergic rhinitis.
Journal of investigational allergology & clinical immunology·2009
Consequences of immunogenicity to the therapeutic monoclonal antibodies ReoPro and Remicade.
Developments in biologicals·2003
Deconditioning in coronary artery disease: an underrecognized problem with contemporary clinical relevance.
Coronary artery disease·2026
Dominant doubly charged ion enabling robust LC-MS/MS quantification of a novel small-molecule antibacterial drug Cefidelbaz in human plasma and its application to pharmacokinetic and protein binding studies.
Journal of pharmaceutical and biomedical analysis·2026
Structural and Mechanistic Studies of ADEPs Yield Potent Antibacterials and a Drug Formulation Strategy for Tuberculosis.
Journal of medicinal chemistry·2026